<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neuroendocrine Tumors &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/neuroendocrine-tumors/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 13:16:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Neuroendocrine Tumors &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Advancements in Living Donor Liver Transplants for Neuroendocrine Tumors</title>
		<link>https://bioengineer.org/advancements-in-living-donor-liver-transplants-for-neuroendocrine-tumors/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 13:15:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Donor Safety** * **Living Donor Liver Transplantation (LDLT):** Makalenin ana konusu ve temel tedavi yöntemi. * **Neuroendocrine Tumors (NETs):** Tedavi edilen spesifik kanser türü. *]]></category>
		<category><![CDATA[İçerik analizine göre en uygun 5 etiket: **Living Donor Liver Transplantation]]></category>
		<category><![CDATA[Makalenin içeriği ve anahtar kelimeleri dikkate alınarak en uygun 5 etiket: **Living donor liver transplantation]]></category>
		<category><![CDATA[Neuroendocrine Tumors]]></category>
		<category><![CDATA[Organ donation** **Açıklama:** 1. **Living donor liver transplantation (Canlı vericili karaciğer nakli):** Makalenin ana konusu ve odağı. 2. **Neuroendocrine tumors (Nöro]]></category>
		<category><![CDATA[patient outcomes]]></category>
		<category><![CDATA[Transplant Oncology]]></category>
		<category><![CDATA[Unresectable Cancer Treatment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advancements-in-living-donor-liver-transplants-for-neuroendocrine-tumors/</guid>

					<description><![CDATA[Living donor liver transplantation (LDLT) has emerged as a promising alternative in the realm of transplant oncology, particularly for patients suffering from unresectable neuroendocrine tumors (NETs). In recent years, ongoing research has increasingly highlighted the role and utility of LDLT as an effective intervention that addresses the complex interplay between cancer management and organ donation. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320297</post-id>	</item>
	</channel>
</rss>
